Business news
The latest business news from across the chemistry-using industries, including mergers and acquisitions, legal and patent disputes, regulation and commercial performance, from the Royal Society of Chemistry's magazine, Chemistry World
-
BusinessBayer ordered to pay more than $2 billion to US cancer victim
Jury decided glyphosate-based Roundup herbicide caused cancer, but company will appeal
-
OpinionGetting into the weeds of the glyphosate debate
Assessments of the risk posed by the controversial herbicide depend on how the evidence is weighed
-
BusinessUS reviews chemical incident prevention planning rules
Risk Management Program has been extended and rolled back under successive governments
-
OpinionWeight loss drug supply races
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of drugs
-
BusinessUS drops chloroprene emissions lawsuit against Denka
Government says lawsuit stretched legal definitions in pursuit of ‘environmental justice’
-
BusinessEnding of US weight-loss drug shortages prompts compounder complaints
Decision ends pharmacies’ permission to prepare versions of GLP-1 hormone mimics
-
OpinionWhy companies are rushing to flatter Trump
Pharma firms are among many pausing diversity programmes and promising domestic investment
-
BusinessNew Trump tariffs worry North American chemical industries
High duties on imports from Canada, Mexico and China raise problems for international supply chains
-
BusinessBiomanufacturing proliferates in chemicals
Fermentation can improve sustainability at competitive costs
-
BusinessChevron and BP cutting thousands of jobs
Oil industry is broadly looking to cut costs, increase oil and gas production and cut renewable investments
-
OpinionJon-Paul Griffiths: ‘Starting a small company is a phenomenal experience’
The chief technology officer of Oxeco on spinning out, supporting entrepreneurs and the difficulties of identifying a market
-
OpinionFluorine makes you an offer you can’t refuse
What might we do if we had a new, electron-donating equivalent element?
-
BusinessNew type of painkiller approved in US
Sodium channel blocker prevents nerves transmitting pain signals
-
BusinessDow to cut 1500 jobs as global chemicals industry reshapes
US firm joins other industry heavyweights in shedding jobs to cut costs
-
BusinessNew Purdue bankruptcy deal cuts out Sacklers’ legal immunity
$7.4 billion proposal will fund support for victims of US opioid crisis
-
OpinionMaintaining mental balance
Finding solace from human affairs in the eypiece of a telescope or microscope
-
BusinessEight workers dead in Indian munitions factory explosion
Seven others injured during incident at state-owned explosives plant
-
BusinessJ&J’s Intra-Cellular deal could signal more mega-mergers for 2025
£15 billion deal for neuroscience biotech aims to replace revenues from patent expiries
-
BusinessRed 3 dye banned in US food and drugs
Additive was already banned in US cosmetics and around the world
-
OpinionRobots queuing up to fail
Claims of an AI revolution in drug discovery are missing the biggest problem